This infographic summarises some key messages from ECDC's technical report Interim public health considerations for COVID-19 vaccination of adolescents in the EU/EEA.
This report summarises results from an analysis conducted by ECDC and Eurofound to understand the impact of selected NPIs introduced from 2020 to 2022 in response to the COVID-19 pandemic on the WLB among EU adults.
What do we know about the SARS-CoV-2 virus causing the COVID19 disease? How does it spread? What are the means one can take to minimise the risk of being infected? Are contacts with pets of any risk?
The number of COVID-19 cases has reached a record high in mainland China, peaking on 2 December 2022. In the past three weeks, incidence has fallen, likely also due to a lower number of tests being carried out, resulting in fewer infections being detected.
These ECDC guidelines detail available options for NPI in various epidemiologic scenarios, assess the evidence for their effectiveness and address implementation issues, including potential barriers and facilitators.
ECDC and EMA have issued a joint statement on adapted COVID-19 vaccines and considerations for their use during the upcoming autumn 2023 vaccination campaigns.